Resumed seem to be enjoying strong revenue growth
FPH revenues 6 months to March down 30% on pcp ….hmmm
Printable View
irrespective of if you think the bold headline was mis - leading it is in my view pretty clear that fph will be having margin contraction too due to the same inflationary factors as resmed
Only to update ...FPH net margins were 22 % pre covid ....went to 26.6 % due to volume cost benefits ...this year maybe 24.5 % ...still healthy .
They are getting some favourable winds too ...ie NZD below 65 ....why only highlight negatives .
I agree all will face inflationary pressures and also FPH is still trying to find its feet . But to think business in distress or downturn is not factually correct .
FPH will take few more months to reverse its SP downtrend when they can surely form a base from where they can confidently grow ahead ...2023 is tough year for FPH SP ...so we long term holders will bear the pain and all the advises of well wishers here :p
see the aussies think resmed margins were crushed too
share price being pulverised as we type down 6%